Serum Institute, Covishield Covid Vaccine, Side-Effects, TTS: “We Disclosed All Rare Side-Effects”: Covid Vaccine Maker Amid Safety Row [Video]

New Delhi:

Amid widespread concern over Thrombosis with Thrombocytopenia Syndrome – a rare side-effect of the Covishield COVID-19 vaccine – the Serum Institute – which made the drug developed by British pharma giant AstraZeneca – has said that all its product packaging had “disclosed all rare to very rare side-effects”, including TTS. The vaccine’s safety “remains paramount”, the company said Wednesday, pointing out the drug, as Covishield, had been “instrumental in saving millions of lives worldwide”.

“We fully understand the ongoing concerns and it is crucial to emphasise our commitment to transparency and safety. From the outset, we disclosed all rare to very rare side-effects, including Thrombosis with Thrombocytopenia Syndrome, in the packaging insert in 2021.”

SII also said that they had discontinued the manufacture of Covishield from December 2021 due to ”the emergence of new mutant variant strains.” This had resulted in  ”the demand for previous vaccines (being) diminished significantly, the company said.

“With India achieving high vaccination …